Page last updated: 2024-12-07

picrocrocin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

picrocrocin: a glucoside of safranal; a bitter-tasting substance; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

picrocrocin : A beta-D-glucoside of beta-cyclocitral; the precursor of safranal. It is the compound most responsible for the bitter taste of saffron. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID130796
CHEBI ID53168
SCHEMBL ID22180
MeSH IDM0232848

Synonyms (29)

Synonym
1-cyclohexene-1-carboxaldehyde, 4-(beta-d-glucopyranosyloxy)-2,6,6-trimethyl-, (r)-
on5b022511 ,
unii-on5b022511
picrocrocin
(r)-4-(beta-d-glucopyranosyloxy)-2,6,6-trimethyl-1-cyclohexene-1-carboxaldehyde
(1r)-4-formyl-3,5,5-trimethylcyclohex-3-en-1-yl beta-d-glucopyranoside
CHEBI:53168
saffron-bitter
138-55-6
C17055
(4r)-2,6,6-trimethyl-4-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclohexene-1-carbaldehyde
picrocrocin [mi]
(4r)-4-(.beta.-d-glucopyranosyloxy)-2,6,6-trimethyl-1-cyclohexene-1-carboxaldehyde
SCHEMBL22180
AC-34396
picrocrocine
DTXSID40160450
AKOS027326831
saffronbitter
safranbitter
1-cyclohexene-1-carboxaldehyde, 4-(beta-d-glucopyranosyloxy)-2,6,6-trimethyl-, (4r)-
Q289866
(r)-2,6,6-trimethyl-4-(((2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)cyclohex-1-ene-1-carbaldehyde
HY-N4114
CS-0032123
AS-79122
1-cyclohexene-1-carboxaldehyde, 4-(ss-d-glucopyranosyloxy)-2,6,6-trimethyl-, (4r)-
(4r)-2,6,6-trimethyl-4-[(2r,4s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclohexene-1-carbaldehyde
E80643

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
beta-D-glucosideAny D-glucoside in which the anomeric centre has beta-configuration.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
crocetin biosynthesis013
crocetin biosynthesis113
Crocetin biosynthesis19

Research

Studies (63)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (4.76)18.2507
2000's11 (17.46)29.6817
2010's36 (57.14)24.3611
2020's13 (20.63)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 37.82

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index37.82 (24.57)
Research Supply Index4.19 (2.92)
Research Growth Index5.27 (4.65)
Search Engine Demand Index53.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (37.82)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews5 (7.69%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other60 (92.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]